Evidence map›Paper›PMID 38197084›Full record

ArticleNeurology. Clinical practice2024

Health and Wellness Coaching for 5-Year Projected Cardiovascular Health: A Randomized Controlled Trial.

Rita V Krishnamurthi, Alain C Vandal, Suzanne Barker-Collo, Susan Mahon, P Alan Barber, Bruce Arroll, Elaine Rush, Hinemoa Elder, Valery L Feigin

Open access · hybridAbstract read
In one paragraph

Article in Neurology. Clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rita V KrishnamurthiNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.ORCID https://orcid.org/0000-0003-0869-2083
Alain C VandalNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.ORCID https://orcid.org/0000-0002-3153-2953
Suzanne Barker-ColloNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.ORCID https://orcid.org/0000-0002-8659-0202
Susan MahonNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.ORCID https://orcid.org/0000-0001-6876-1613
P Alan BarberNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.ORCID https://orcid.org/0000-0003-2469-9023
Bruce ArrollNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.ORCID https://orcid.org/0000-0002-0451-9462
Elaine RushNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.ORCID https://orcid.org/0000-0001-7713-6203
Hinemoa ElderNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.
Valery L FeiginNational Institute for Stroke and Applied Neurosciences (RVK, SM, ER, VLF), School of Clinical Sciences, Auckland University of Technology; Department of Statistics (ACV), The University of Auckland; Ko Awatea, Counties Manukau Health; Department of Psychology (SB-C); Department of Neurology (PAB); Department of General Practice (BA), The University of Auckland; and Te Whare Wānanga o Awanuiārangi (HE), Auckland, New Zealand.ORCID https://orcid.org/0000-0002-6372-1740
University of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Evidence of effective multifactorial lifestyle interventions for primary stroke prevention is lacking, despite the significant contribution of lifestyle to stroke burden. We aimed to determine the efficacy of health and wellness coaching (HWC) for primary stroke and cardiovascular disease (CVD) prevention in adults at a moderate-to-high CVD risk. Methods: This was a parallel, 2-arm, open-label, single-blinded, phase III randomized controlled trial to determine the efficacy of HWC for primary stroke prevention in individuals 30 years and older with a 5-year CVD risk ≥10% as measured by 5-year absolute CVD risk (as measured by the PREDICT tool) at 9 months post-randomization. Eligible participants were those with a 5-year CVD risk ≥10%, with no history of stroke, transient ischemic attack, or myocardial infarction. The relative risk reduction (RRR) and odds ratios (OR) were evaluated separately in those at moderate (10%-14%) 5-year CVD risk and those at high risk (≥15%) at baseline. The Life's Simple 7 (LS7) score for lifestyle-related CVD risk, as the indicator of cardiovascular health, was a key secondary outcome. Results: Of a total of 320 participants, 161 were randomized to the HWC group and 159 to the usual care (UC) group. HWC resulted in a statistically significant RRR of -10.9 (95% CI -21.0 to -0.9) in 5-year CVD risk in the higher CVD risk group but no change in the moderate risk group. An improvement in the total LS7 score was seen in the HWC group compared with the UC group (absolute difference = 0.485, 95% CI [0.073 to 0.897], Discussion: Health and wellness coaching resulted in a significant RRR in the 5-year CVD risk compared with UC at 9 months post-randomization in patients with a high baseline CVD risk. There was no improvement in CVD risk in the moderate risk group; hence, this study did not meet the primary hypothesis. However, this treatment effect is clinically significant (number needed to treat was 43). The findings suggest that HWC has potential if further refined to improve lifestyle risk factors of stroke.

Identifiers

PMID38197084
PMCPMC10775165
OpenAlexW4390575041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.